跳至主要内容
临床试验/ISRCTN84974248
ISRCTN84974248进行中(未招募)2 期

Paracetamol for Acute Renal Injury in Severe Malaria Trial (PARIST)

European & Developing Countries Clinical Trials Partnership0 个研究点目标入组 40 人开始时间: 2020年12月8日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37524553/ (added 01/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children aged >6 months to <12 years
  • 2. Positive RDT for P. falciparum malaria at admission
  • 3. One of the following features of severe malaria confirmed haemoglobinuria, impaired consciousness and/or severe respiratory distress
  • 4. Guardian or parent willing and able to provide consent

排除标准

  • 1. Surgery
  • 2. Acute trauma or burns
  • 3. Known allergy to paracetamol
  • 4. Impaired liver function tests
  • 5. Known chronic renal failure or suspected non-malarial causes of renal impairment
  • 6. Refusal to consent

研究者

相似试验